PLEASANTON, Calif.,
Dec. 1, 2021 /PRNewswire/ -- 10x
Genomics (Nasdaq: TXG), a life sciences leader focused on mastering
biology to advance human health, today announced that Chromium X
has been named one of The Scientist's 2021 Top 10 Innovations, an
annual list of newly released products that have the potential to
generate the biggest impact on scientific research. This
recognition marks the fifth consecutive year that a 10x Genomics
product made the list, with a total of seven products appearing as
Top 10 Innovations since 2015.
Chromium X, a next-generation single-cell platform launched in
July that enables cost-effective high-throughput experiments, is
the latest innovation in the company's leading portfolio of
instruments, consumables and software to help researchers
accelerate the mastery of biology. Other 10x products to earn this
recognition include:
- Chromium Controller (2017) - The product that
began the company's five-year streak, the Chromium Controller uses
advanced microfluidics to enable integrated analysis of single
cells at high resolution and large scale.
- Single Cell Immune Profiling (2018) - This product
enables researchers to study the body's adaptive immune response to
different types of infections and identify the specific cell types
that respond to immune system activation.
- Chromium Single Cell ATAC (Assay for Transposase
Accessible Chromatin) (2019) - This product scaled the throughput
of single-cell ATAC sequencing from a few hundred processed
manually to thousands or tens of thousands of cells per run.
- Visium Spatial Gene Expression Solution (2020) - Built
on the technology and expertise from 10x's acquisition of Spatial
Transcriptomics, the Visium Spatial Gene Expression Solution
advanced the field of spatial analysis by revealing exactly where
in a tissue sample that gene expression is taking place.
- Chromium Single Cell Multiome ATAC + Gene Expression
(2020) - Following the success of the Single Cell ATAC product,
this product enables researchers to harvest both epigenetic and
gene expression data from individual nuclei.
The award-winning products are a testament to the company's
multidisciplinary expertise and robust R&D pipeline. To date,
the company has invested more than $1
billion in R&D, launched more than 20 pioneering
products, and built a portfolio of more than 1,200 issued patents
and patent applications.
"To solve the most important biological questions of our time
and develop the life-saving cures of tomorrow, researchers need the
best possible tools, with ever-increasing capabilities," said
Ben Hindson, Co-Founder, President
and Chief Scientific Officer of 10x Genomics. "We're honored and
humbled to be consistently recognized by The Scientist for our
culture of innovation and strong cadence of technological
advancement. This velocity of innovation, development and execution
is a testament to the incredible cross-functional talent we have
cultivated. We'll continue to push the boundaries of what's
possible to bring our customers higher scale, resolution and
efficiency to fuel scientific discovery and ultimately advance
human health."
To see the full list of The Scientist's 2021 Top 10 Innovations,
please visit
www.the-scientist.com/features/2021-top-10-innovations-69438.
About 10x Genomics
10x Genomics is a life science technology company building
products to interrogate, understand and master biology to advance
human health. The company's integrated solutions include
instruments, consumables and software for analyzing biological
systems at a resolution and scale that matches the complexity of
biology. 10x Genomics products have been adopted by researchers
around the world including in all of the top 100 global research
institutions as ranked by Nature in 2020 based on publications and
all of the top 20 global pharmaceutical companies by 2020 research
and development spend and have been cited in over 3,000 research
papers on discoveries ranging from oncology to immunology and
neuroscience. The company's patent portfolio comprises more than
1,200 issued patents and patent applications.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange
Commission, its website (www.10xgenomics.com), press releases,
public conference calls, public webcasts and its social media
accounts as means of disclosing material non-public information and
for complying with its disclosure obligations under Regulation
FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/10x-genomics-recognized-on-the-scientists-top-10-innovations-list-for-fifth-consecutive-year-301435676.html
SOURCE 10x Genomics, Inc.